Oncology Institute Inc - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE

Ticker Exchange SIC # Website Latest Ticker
TOI Nasdaq 8011 https://theoncologyinstitute.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Oncology Institute Inc

Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI) - Nov 16th, 2023 10:04 am
Even With A 49% Surge, Cautious Investors Are Not Rewarding The Oncology Institute, Inc.'s (NASDAQ:TOI) Performance Completely - Nov 10th, 2023 10:02 am
The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens - Nov 8th, 2023 10:50 pm
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance - Nov 8th, 2023 9:05 pm
Oncology Institute Decline Means Insider Profits Down To US$113k - Nov 7th, 2023 3:34 pm
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call - Oct 18th, 2023 12:03 pm
The Oncology Institute Names Jeremy Castle as Chief Operations Officer - Oct 11th, 2023 8:05 pm
The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit - Sep 26th, 2023 8:05 pm
The Oncology Institute Regains Compliance with Nasdaq Listing Requirements - Sep 18th, 2023 12:00 pm
Private equity firms in The Oncology Institute, Inc. (NASDAQ:TOI) are its biggest bettors, and their bets paid off as stock gained 44% last week - Sep 12th, 2023 10:21 am
Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology - Aug 9th, 2023 12:10 pm
The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance - Aug 8th, 2023 8:40 pm
Oncology Institute (NASDAQ:TOI) shareholders have endured a 90% loss from investing in the stock three years ago - Aug 2nd, 2023 10:16 am
The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations - Jul 31st, 2023 12:00 pm
The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call - Jul 18th, 2023 12:00 pm
The Oncology Institute Announces Leadership Transition - Jun 12th, 2023 10:00 am
The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research - Jun 9th, 2023 12:00 pm
The Oncology Institute to Open Project Southland - Jun 7th, 2023 12:00 pm
The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting - May 31st, 2023 12:01 pm
The Oncology Institute to Participate at Upcoming Investor Conferences - May 31st, 2023 12:00 pm